Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Child Adolesc Psychopharmacol ; 17(6): 831-42, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18315454

ABSTRACT

INTRODUCTION: The Life Participation Scale for Attention-Deficit/Hyperactivity Disorder (ADHD)-Child Version (LPS-C) was developed to capture treatment-related improvements in adaptive functioning, including quality of life, social development, and emotion regulation, that may be missed by scales that assess only the 18 ADHD symptoms in the Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV). The 24-item LPS-C is intended to augment traditional ADHD measures. This analysis assessed the scale's psychometric properties. METHODS: The LPS-C was completed by the investigators while questioning the parents of 979 children in three placebo-controlled clinical trials that measured the effects of atomoxetine for treating ADHD. In addition to a factor analysis, assessments of responsiveness; internal consistency; item-to-total correlations; and convergent, divergent, and discriminant validity were completed. RESULTS: The LPS-C showed evidence of internal consistency and convergent, divergent, and discriminant validity. The factor analysis suggested two subscales (labeled the Self-Control and Agreeable subscales). The LPS-C demonstrated responsiveness in two of the three trials. The effect sizes suggest responsiveness between that for psychosocial measures and core symptom measures. CONCLUSIONS: The LPS-C appears to be a valid research and clinical instrument for assessing change in ADHD-related adaptive functioning that may not be captured by traditional measures of core ADHD symptoms.


Subject(s)
Attention Deficit Disorder with Hyperactivity/drug therapy , Psychiatric Status Rating Scales , Quality of Life , Adolescent , Adrenergic Uptake Inhibitors/therapeutic use , Atomoxetine Hydrochloride , Central Nervous System Stimulants/therapeutic use , Child , Emotions/drug effects , Factor Analysis, Statistical , Female , Humans , Male , Methylphenidate/therapeutic use , Multicenter Studies as Topic , Parents , Propylamines/therapeutic use , Psychometrics/methods , Randomized Controlled Trials as Topic , Reproducibility of Results , Social Behavior
2.
J Atten Disord ; 8(3): 127-35, 2005 Feb.
Article in English | MEDLINE | ID: mdl-16009661

ABSTRACT

Poor outcomes in ADHD may be related to problematic social functioning and consequences of social rejection. This study examines how ADHD symptom expression affects mood and social rejection. Working from findings in depression that describe maintenance through negative interpersonal interactions, the authors seek to examine this theory's applicability to poor outcomes in ADHD. In a completely randomized design, 130 participants are exposed to one of several videotape segments that include displays of ADHD, depression, and social anxiety. A normal control is also used. All abnormal videotapes are met with greater rejection than the control. Displays of ADHD elicit similar levels of rejection to those elicited by displays of depression. Additionally, ADHD elicits greater levels of hostile mood, whereas depression elicits high levels of depression and fatigue. Implications for an interpersonal theory of vulnerability in ADHD are discussed along with implications for future research, prevention, and intervention.


Subject(s)
Attention Deficit Disorder with Hyperactivity/epidemiology , Rejection, Psychology , Social Behavior , Adult , Anxiety/diagnosis , Attention Deficit Disorder with Hyperactivity/diagnosis , Depression/diagnosis , Female , Humans , Interpersonal Relations , Male , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL
...